1. Center for Drug Evaluation and Research, FDA. Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action (2003).
https://www.fda.gov/media/70867/download
. Accessed 12 Aug. 2009
2. U.S. Food and Drug Administration, Product-Specific Guidances for Generic Drug Development (2019).
https://www.fda.gov/drugs/guidances-drugs/product-specific-guidances-generic-drug-development
. Accessed 10 Sep. 2019
3. Food and Drug Administration Safety and Innovation Act, Pub. L. No. 112–144, Title iii
4. U.S. Food and Drug Administration. GDUFA II Commitment Letter
5. U.S. Food and Drug Administration. Science & Research